CureVac N.V. Ordinary Shares
Symbol: CVAC (NASDAQ)
5.42
▼ (-0.64%) -0.035
Company Description:
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
Key Stats
- Today's Open: $5.401
- Today's High: $5.435
- Today's Low: $5.401
- Today's Volume: 337.83K
- Yesterday Close: $5.45
- Yesterday High: $5.45
- Yesterday Low: $5.4
- Yesterday Volume: 532.00K
- Last Min Volume: 4
- Last Min High: $5.415
- Last Min Low: $5.415
- Last Min VWAP: $5.415
Company Profile
- Name: CureVac N.V. Ordinary Shares
- Website: https://www.curevac.com
- Listed Date: 2020-08-14
- Location: ,
- Market Status: Active
- CIK Number: 0001809122
- SIC Code:
- SIC description:
- Market Cap: $1.23B
- Round Lot: 100
- Outstanding Shares: 225.17M
- Asset Type: CS
RECENT FILINGS FOR CVAC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-15 | 6-K | View |
| 2025-08-13 | SCHEDULE 13D | View |
| 2025-08-11 | 425 | View |
| 2025-08-08 | 425 | View |
| 2025-08-08 | 6-K | View |
| 2025-08-01 | SCHEDULE 13D/A | View |
| 2025-06-26 | 6-K | View |
| 2025-06-24 | 6-K | View |
| 2025-06-17 | 425 | View |
| 2025-06-16 | 6-K | View |
| 2025-06-16 | SCHEDULE 13D/A | View |
| 2025-06-12 | 425 | View |
| 2025-06-12 | 425 | View |
| 2025-06-12 | 425 | View |
| 2025-06-12 | 425 | View |
| 2025-06-12 | 425 | View |
| 2025-06-12 | 6-K | View |
| 2025-06-12 | SC14D9C | View |
| 2025-05-23 | 6-K | View |
| 2025-05-20 | 6-K | View |
Latest News on CVAC